Among them, the combination strategy of anti- Tumor Necrosis Factor Alpha (anti-TNF-α) agents and anti-VEGF drugs has shown a synergistic effect in neovascular glaucoma (Zhou et al., 2023; Carrola et al., 2021). The gene discussed is VEGFA; the disease is neovascular glaucoma.